Printer Friendly

Ryogen is Awarded New Patent.

Patented DNA Sequence Encodes a Protein Implicated in Diabetes, Metabolic Syndrome, Immune Dysfunctions and Other Diseases

SUFFERN, N.Y. -- Ryogen LLC, a genomic start-up company, has been awarded a new patent titled "Isolated Genomic Polynucleotide Fragments from Chromosome 7".

U.S. patent No. 7,588,915, issued by the U.S. Patent and Trademark Office, claims isolated genomic polynucleotide fragments that encode human adipocyte enhancer binding protein 1 (AEBP1), complementary polynucleotides, vectors and host cells containing these fragments and a method for obtaining AEBP1.

"The protein encoded by the claimed sequences is thought to play a role in diabetes and metabolic syndrome, obesity, inflammation, immune processes, osteopenia and atherogenesis," says Dr. James W. Ryan, the named inventor and Ryogen's Chief Scientist.

"The new patent is an important addition to Ryogen's intellectual property portfolio," says Valeria Poltorak, the company's Executive Vice President. "We are planning to offer this patent for licensing to make it widely available to researchers to facilitate the development of new diagnostic and treatment methods," she adds.

About Ryogen LLC

Ryogen LLC, headquartered in Suffern, N.Y., is a genomic start-up and a portfolio company of an idea incubator IP Holdings LLC which is also located in Suffern, N.Y. Ryogen is managed by General Patent Corporation, a premier intellectual property (IP) licensing and enforcement boutique. For further information about Ryogen, contact Valeria Poltorak, Ryogen LLC, Montebello Park, Suffern, NY 10901-3746; Telephone: 845-368-4000 x111; E-mail:; or visit

About IP Holdings LLC

IP Holdings LLC is an IP-centric merchant banking organization that operates an idea incubator with a specific focus on patent commercialization. IP Holdings LLC is affiliated with General Patent Corporation, a leading patent licensing and enforcement firm. For further information on IP Holdings, contact IP Holdings LLC, Montebello Park, Suffern, NY 10901-3746; Telephone: (845) 368-4000; E-mail:; or visit
COPYRIGHT 2009 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1U2NY
Date:Nov 11, 2009
Previous Article:Fitch: U.S. Credit Card Profitability to Remain Challenged.
Next Article:MG Thomas A. Benes (USMC, Ret.) Joins Alion.

Related Articles
Ryogen licenses human aminopeptidase P gene patent to R&D systems.
Ryogen licenses human aminopeptidase P gene patent to OriGene.
Illumina and Affymetrix reach $90 Million Settlement.
Patent redux.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters